This inventor holds 3 USPTO granted patents, plus 1 CIPO patent and 1 EPO patent. Top assignees: Haimbio Co., Ltd., Holosmedic. Active years: 2019-2024.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Gyeonggi-do, KR (2019)
- Seoul, KR (2020)
Company Filing History:
Years Active: 2019-2024
Title: Ki Cheong Park: Innovator in Cancer Treatment
Introduction
Ki Cheong Park is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compositions. With a total of 3 patents, Park's work focuses on enhancing anticancer activity and improving treatment outcomes for patients.
Latest Patents
One of Park's latest patents is titled "Diketopiperazine derivatives as calcium ATPase inhibitor for enhancing anticancer activity." This invention relates to a novel compound and a pharmaceutical composition designed to enhance the anticancer activity of existing treatments. The composition includes a compound represented by a specific formula, which effectively induces proliferation inhibition and death of cancer cells, thereby contributing to cancer treatment. Another significant patent is for a "Pharmaceutical composition for preventing or treating cancer." This composition contains a glucose uptake inhibitor and a sesquiterpene lactone, which work together to inhibit the proliferation of both cancer cells and cancer stem cells. This innovative approach aims to prevent and treat cancer while also addressing issues such as resistance, metastasis, and recurrence.
Career Highlights
Throughout his career, Ki Cheong Park has worked with various companies, including Haimbio Co., Ltd. and Holosmedic. His experience in these organizations has allowed him to further his research and development efforts in the pharmaceutical industry.
Collaborations
Park has collaborated with notable individuals in his field, including Jae Ho Cheong and Eun Sung Park. These partnerships have contributed to the advancement of his research and the successful development of his patents.
Conclusion
Ki Cheong Park is a distinguished inventor whose work in cancer treatment has the potential to make a significant impact on patient care. His innovative patents and collaborations highlight his commitment to advancing medical science and improving treatment options for cancer patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile